background image

Paid Clinical Trials Durham

Discover 1,545 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & ResponsiveNew

A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza

for
Influenza
Location: Durham NC, Winston-Salem NC, Salisbury NC, Monroe NC,
Sponsor: Cidara Therapeutics Inc.

Sex: All

Age: 12+

Code: NCT07159763

Phase3, Recruiting
Active & ResponsiveNew

Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors

for
Obesity, Cancer, Physical Activity, Cancer Survivorship, Diet
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18 - 39

Code: NCT06848491

Recruiting
Active & ResponsiveNew

Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study

for
Breast Cancer, Breast Neoplasms
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: Female

Age: 20 - 70+

Code: NCT07214610

Recruiting
Active & ResponsiveNew

Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells

for
Monkeypox (Mpox)
Location: Cary NC
Sponsor: Bavarian Nordic

Sex: All

Age: 18 - 49

Code: NCT07199569

Phase2, Recruiting
Active & ResponsiveNew

A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

for
Influenza, Human
Location: Greensboro NC, Newport News VA, North Charleston SC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07121192

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Oxygen Toxicity: Mechanisms in Humans

for
Oxygen Toxicity, Hypercapnia, Seizures
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18 - 45

Code: NCT05761756

Recruiting
Active & Responsive

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

for
Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung
Location: Durham NC, Kansas City MO, Dallas TX, Santa Rosa CA
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT05853575

Phase2, Recruiting
Active & Responsive

A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

for
Propionic Acidemia
Location: Durham NC, Philadelphia PA, New York NY, Ann Arbor MI,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 1+

Code: NCT05130437

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy (MSA): A Safety and Efficacy Study

for
Multiple System Atrophy
Location: Durham NC, Alexandria VA, Washington D.C. DC,
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Sex: All

Age: 30+

Code: NCT06568237

Phase2, Recruiting
Active & Responsive

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

for
Glioblastoma, IDH1 Gene Mutation, IDH2 Gene Mutation,
Location: Durham NC, Baltimore MD, Philadelphia PA, Hackensack NJ,
Sponsor: University of California, San Francisco

Sex: All

Age: 13 - 39

Code: NCT03749187

Phase1, Recruiting